A Project Report

On

“Understanding Consumer Awareness in Relation to vaccination”

Submitted in the fulfillment of the requirement

For the award of the degree of

“Bachelor of Business Administration”

Submitted to

PPN COLLEGE, KANPUR

(CSJM University)

By

Pragya Srivastava

0301097

Under the guidance of

Pooja Vidyarthi

Head of the Department

BBA Department, PPN College

Kanpur (2021)

ACKNOWLEDGEMENT

The project entitled “Understanding Consumer Awareness in Relation to Vaccination” tries

to understand the consumer awareness in relation to vaccination, health and current
pandemic. This project tries to understand various aspects and factors that has affected people
choice while making decisions in relation to the current pandemic.
This project report is on “Understanding Consumer Awareness in Relation to Vaccination”.
This project aims at studying the customer knowledge in relation to vaccination and current
pandemic. Its objectives are to know how their knowledge about vaccinations affects their
choice of choosing the right vaccination and what are the possible side-effects associated
with it.

I would like to express my sincere gratitude and regards to my guide Mrs. Pooja Vidyarthi for
her constant inspiration, supervision and invaluable guidance during the making of this
project.

I would extend my heartfelt regards to all the faculty members of the Department of
Professional & Self Finance Courses, PPN College, Kanpur for their valuable suggestions.

Roll No-0301097
Student declaration

I Pragya Srivastava student of BBA PPN College, Kanpur hereby declare that the Project
work entitled “Consumer Awareness in Relation to Vaccination” compiled and submitted by
me under the guidance of Mrs. Pooja Vidyarthi is my original work.

Whatever information furnished in this project report is true to the best of my knowledge.

Name: Pragya Srivastava

BBA VIth Semester

Roll no:0301097
 GENERAL INFORMATION

Scientistic first identified a human coronavirus in 1965. It caused a common cold. Later that
decade, researchers found a group of similar human and animal viruses and named them after
their common appearance.

COVID-9 is a new virus that has been identified for the first time in the city of Wuhan, the
Capital of the Hubei Province in mainland China. It was identified after people developed
pneumonia without an evident cause and where current vaccines and treatment methods were
not effective. There have also been about 4600 fatalities there, exceeding those from SARS.
Cases have also been reported outside China, in Hong Kong, South Korea, Iran, Italy ,
Australia , Thailand , France , Spain etc. totaling over 200 countries. India reported its first
case towards the end of January 2020.

Symptoms include – Fever, coughing, muscle pain, fatigue, breathing issues, can cause
pneumonia (infection of one or both lungs, can be fatal. The virus is believed to have
originated in a seafood market in Wuhan that was involved in the illegal sale of wildlife.
Many patients of the virus had some link to the market, suggesting an animal-to-human
spread.

The National lockdown of 21 days announced on 24 th March 2020 by PM Narendra Modi

was extended till 3rd May 2020. The first case of the Novel coronavirus in India was
confirmed in Kerala

The COVID-19 pandemic is an ongoing global pandemic of coronavirus disease 2019

(COVID-19) which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-
COV-2). The virus was first identified in December 2019 in Wuhan the 7 th largest city in
China. The WORLD HEALTH ORGANISATION declared a Public Health Emergency of
International concern regarding COVID-19 on 30 January 2020, and later declared a
pandemic on 11 March 2020. As of 16 June 2021, more than 176 million cases have been
confirmed, with more than 3.82 million confirmed deaths attributed to COVID-19, making it
one of the deadliest pandemics in history.

The severity of COVID-19 symptoms is highly variable, ranging from unnoticeable to life-
threatening. Severe illness is more likely in elderly COVID-19 patients, as well as those who
have underlying medical conditions. COVID-19 transmits when people breathe in air
contaminated by droplets and small airborne particles. The risk of breathing these in is
highest when people are in proximity, but they can be inhaled over long distances,
particularly indoors. Transmission can also occur if splashed or sprayed with contaminated
fluids, in the eyes, nose or mouth and rarely via contaminated surfaces. People remain
contagious for up to 2o days and spread the virus even if they do not develop any symptoms.
India reported positive cases of the new strain around the end of December 2020.

Recommended preventive measures includes social distancing, wearing face masks in public,
ventilation and air-filtering, hand washing, covering one’s mouth when sneezing or coughing,
disinfecting surfaces and monitoring and self-isolation for people exposed or symptomatic.
Several vaccines have been developed and widely distributed since December 2020.

The pandemic has resulted in significant global social and economic disruption, including the
largest global recession since the Great Depression of the 1930s. It has led to widespread
supply shortages exacerbated by panic buying, agricultural disruption and food shortages.
However, there have been decreased emissions of pollutants and greenhouse gases.
Numerous educational institutions and public areas have been partially or fully closed, and
many events have been cancelled or postponed. Misinformation has circulated through social
media and political tensions have been exacerbated. The pandemic has raised issues of racial
and geographic discrimination, health equity and the balance between public health
imperatives and individual rights. Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is a novel severe acute respiratory syndrome coronavirus. It was first isolated from
three people with pneumonia connected to the cluster of acute respiratory illness cases in
Wuhan. All structural features of the novel SARS-CoV-2 virus particle occur in related
coronaviruses in nature.

Outside the human body, the virus is destroyed by household soap, which bursts its protective
bubble. A COVID-19 vaccine is a vaccine intended to provide acquired immunity against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing
coronavirus disease 2019 (COVID-19). Prior to the COVID-19 pandemic, there was an
established body of knowledge about the structure and function of coronaviruses causing
diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory
syndrome (MERS), which enabled accelerated development of various vaccine technologies
during early 2020. On 10 January 2020, the SARS-CoV-2 genetic sequence data was shared
through GISAID, and by 19 March, the global pharmaceutical industry announced a major
commitment to address COVID-19.
Many countries have implemented phased distribution plans that prioritize those at highest
risk of complications, such as the elderly, and those at high risk of exposure and transmission,
such as healthcare workers.

However, due to humans the pandemic has also provided cover for illegal activities such as
deforestation of the Amazon rainforest and increased poaching in Africa. The hindering of
environmental diplomacy efforts in combination of late capitalism also created economic
fallout that some predict will slow investment in green energy technologies.

Social distancing and lockdown rules were employed in India, which however had an
additional impact on the economy, human living and environment got a positive one. The
emergence of COVID-19 pandemic has severely impacted individuals from all the walks of
life. The rapid spread of the disease to nearly all parts of the country has posed enormous
health, economic, environmental and social challenges to the entire human population. In the
absence of any effective drugs and vaccines for treatment, social distancing and other
preventive measures are the only alternatives. Lockdown is among one of the options
suggested by WHO to reduce spread of the virus. India was quick to close its international
borders and enforce the world’s largest COVID lockdown on March 22,2020. Lockdowns to
prevent the community transmission of COVID-19 pandemic has confined the people at
home and imposed social restrictions, which is expected to cause alterations in circadian
driven sleep-wake schedule and its associated lifestyle behaviors.

Good health is not just the absence of disease or illness, it is a state of complete physical,
mental and social well- being. This means eating a balanced diet, getting regular exercise,
avoiding tobacco and drugs and getting plenty of rest.

The lasting impact of COVID-19 pandemic and associated restrictions are bound to be
significant on lifestyle- related behavior including diet, physical activity and sleep which is
one of the important components in the management of diabetes mellitus and metabolic
syndrome.

The children are minimally susceptible to COVID-19 Corona virus disease; however, they
are hit the hardest by psychosocial impact of this pandemic. Being quarantined in homes and
institutions may impose greater psychological burden than the physical sufferings caused by
the virus. School closure, lack of outdoor activity, aberrant dietary and sleeping habits are
likely to disrupt children’s usual lifestyle and can potentially promotes monotony, distress,
impatience, annoyance and varied neuropsychiatric manifestations. Incidences of domestic
violence, child abuse, adulterated online contents are on the rise.

Children of single parent and frontline workers suffer unique problems. The children from
marginalized communities are particularly susceptible to the infection and may suffer from
the extended ill consequences of this pandemic, such as child labor, child trafficking, child
marriage, sexual exploitation and death etc.

Parents, pediatricians, psychologists, social workers, hospitals authorities, government

organizations have important roles to play to mitigate the psychosocial ill effects of COVID
-19 on children and adolescents.

To provide the basic amenities, social security, medical care and to minimize the educational
inequalities among the children of the different strata of the society are foremost priorities.
 INTRODUCTION

Consumer awareness means being conscious of having knowledge about the various
consumer production laws, redress mechanism and the consumer rights which include right to
protection of health and safety from goods and services that the consumer buy, right to be
informed about the quality , price, potency and purity.

COVID-19 is an infectious disease caused by the recently discovered novel Corona virus.
This disease was unknown before the outbreak began in Wuhan, China in December 2019.
The most common symptoms of COVID-19 are fever, tiredness and dry cough. Some
patients may have aches and pain, nasal congestion, runny nose, sore throat or diarrhea and in
case of serious illness develop difficulty in breathing. Older people and those with underlying
medical problems like blood pressure, heart problems or diabetes mellitus are more prone to
develop serious illness. The World Health Organization has declared the COVID-19 as a
pandemic and a global health emergency. The number of cases of COVID-19 infection in
India is increasing day by day. With the spread in many states, general measures like
isolation, social distancing and regular us of masks and frequent washing of hands are being
propagated. The Government is also taking effective steps for early identification of the
infection and providing adequate preventation and timely medical care. The coming days will
now decide whether there will be flattering of the curve or considerable increase in the
number. In either case, the medical fraternity is geared up to handle the situation. However,
when the infection affects a large number of populations, the present healthcare system will
be strained. It is expected that majority of COVID-19 positive patients, with mild or moderate
symptoms, may recover on their own. Certain numbers of patients who are expected to suffer
from severe to critically ill situations mainly belong to 60 years and above age group.

India’s huge immunization drive began on 16 January 2021. The health ministry is aiming to
vaccinate four priority groups: healthcare workers, people over 50, public workers, and those
under 50 with comorbidities with the former two groups to be inoculated first in an initial
rollout to 30 million people.

As of

Safe and effective vaccines are a game-changing tool but for the foreseeable future must
continue wearing masks, cleaning our hands, ensuring good ventilation indoors, physically
distancing and avoiding crowds. Being vaccinated does not mean that we can throw caution
to the wind ad put ourselves and others at risk.

Equitable access to safe and effective vaccines is critical to ending the COVID-19 pandemic,
so it is hugely encouraging to see so many vaccines proving and going into development.
WHO is working tirelessly with partners to develop, manufacture and deploy safe and
effective vaccines. India’s National COVID-19 Vaccination strategy is based on scientific
and epidemiological evidence and focuses on systematic end-to-end planning. This strategy
derives guidance from Global Best Practices.

The Union Govt., in close collaboration with State Governments and Union territories
administration, has been working over a period to ensure that maximum number of Indians
are able to get the vaccine in the shortest possible time.

Phase-I of the National Covid-19 Vaccination Strategy was launched on 16th January 2021
and focused on protecting Health Care Workers (HCWs) and Front-Line Workers (FLWs).

Phase-II was initiated from 1st March 2021 and 1st April 2021 and focusses on protecting
the most vulnerable i.e. population more than 45 years of age that accounts for more than
80% Covid mortality in the country.

In its phase-III, the National Vaccine Strategy aims at liberalized vaccine pricing and scaling
up of vaccine coverage. This would, on the one hand, incentivize vaccine manufacturers to
rapidly scale up their production and on the other hand, it would also attract new vaccine
manufacturers. It would make pricing, procurement and administration of vaccines more
flexible and ensure augmented vaccine production as well as wider availability of vaccines in
the country.
 Throughout these phases, Government has coordinated and worked with research institutes,
private companies and has leveraged the strength of India’s vaccine manufacturing capability
as well as brought about far-reaching governance changes in India’s drug/vaccine regulatory
system. This resulted in grant of “Restricted Use in Emergency Situation” (also referred to as
“Emergency Use Authorization-EUA) to two indigenously manufactured vaccines and one
vaccine that is presently manufactured abroad but would eventually be manufactured in India.
Govt. of India has been in regular touch with each vaccine manufacturer to facilitate public
private collaborative research, trials and product development. Multiple Inter-Ministerial
teams have been deputed by Govt. of India to various manufacturing sites to understand each
one’s requirements and to provide pro-active and customized support in the form of grants,
advance payments, facilitating more sites for production etc. to significantly augment vaccine
production capacities. Government of India has ensured participation of the private sector in
the vaccination drive right from the beginning.

My research report deals with two vaccines namely- “COVAXIN and COVISHIELD”

According, to the WHO there are over 50 vaccine candidates for COVID-9 in various stages
of clinical trials.

1. COVAXIN
This is India’s first indigenously developed COVID-19 vaccine. It is developed by
Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR)-
National Institute of Virology.
The vaccine is developed using Whole-Virion Inactivated Vero Cell derived platform
technology. Inactivated vaccines do not replicate and are therefore unlikely to revert
and cause pathological effects. They contain dead virus, incapable of infecting people
but still able to instruct the immune system to mount a defensive reaction against an
infection.

KEY FEATURES-

 COVAXIN is included along with immune-potentiators, also known as vaccine

adjuvants, which are added to the vaccine to increase and boost its immunogenicity. It is a 2-
dose vaccination regimen given 28 days apart.
 It is a vaccine with no sub-zero storage, no reconstitution requirement, and ready to
use liquid presentation in multi-dose vials, stable at 2-8oC
 Pre-clinical studies: Demonstrated strong immunogenicity and protective efficacy in
animal challenge studies conducted in hamsters & non-human primates.
 The vaccine received DCGI approval for Phase I & II Human Clinical Trials in July ,
2020.

2. COVISHIELD

Covishield is co-developed by the University of Oxford and British-Swedish company

AstraZeneca in collaboration with the Serum Institute of India.

This is a vaccine made to immunise people against SARS-CoV-2 or coronavirus or COVID-

19. This is not a treatment of Covid but an emergency solution to prevent the transmission of
the virus to a larger extent.
The vaccine is effective along with Covid appropriate behaviour that includes wearing of a
mask, physical distancing, hand hygiene, etc. Two doses of covishield is to be given to
provide complete the immunization process. Each dose is 0.5 ml and to be given at 4-6 weeks
intervals.
If the person has received the first dose, he/she can be given the second dose within 4-6
weeks depending upon their healthcare provider. Some overseas research is done on this
vaccine also mentions that the second dose may be given up to 12 weeks, but one need to
consult their doctor first.
If in case, you fail to get the second dose as per the advised schedule, seek help from an
experienced healthcare provider. For full protection, getting the second dose is a must. It is
only after 2-3 weeks of receiving the second dose, you would become immune to this life-
threatening virus.

Of the two vaccines approved, Covishield is better known. It’s a version of the Oxford
University – AstraZeneca vaccine that was found to have an average efficacy of 70.4% in a
peer reviewed study. Covishield is an Indian version made by the Serum Institute of India ,
and phase iii trials on Indian Cohort have begun, with 1600 people entrolled in November.
Covaxin is India’s first home produced vaccine against Covid -19. It was developed by
Bharat Biotech in Collaboration with the Indian Council of Medical Research and the
National Institute of Virology , and 25 800 people have been registered for trials across the
country. On 21 January , The Lancet published Covaxin’s phase 1 trial data, giving it a green
light for safety and stating that it generates adequate immune response, but said further
efficacy trials were warranted.

Both the vaccines require two doses and work by priming the immune system with a SARS-
CoV-2 spike protein. Covishield uses a weakened version of adenovirus , while Covaxin uses
an inactivated SARS-CoV-2 virus extracted from an asymptomatic plant.

The emergency approval of the vaccines does not mean that safety was compromised in any
ways, says Samiran Panda , chief of epidemiology and communicable diseases at the Indian
Council of Medical Research.

“We will continue to assess and monitor efficacy data, which should be made public once
phase 3 and 4 of the trials is complete, but allowing the vaccine for use in prioritized now
could mean preventing fresh infections, saving people from suffering the crippling effects of
long covid and even death,” he told The BMJ. Potential vaccine recipients will be given an
information fact sheet, asked to provide informed consent, and monitored over a longer
period of time. In case of any adverse event, compensation would be offered, Panda says.

The All India People’s Science Network, representing multiple scientists has described
approval of Covaxin as hasty. “This achievement will be hailed as a major Indian Scientific
achievement once efficacy of data are released but by this hasty approval, the government
has shot himself in the foot,” the network said in a statement.
 LITERATURE REVIEW

COVID-19 was the defining event of 2020. Its social, economic, political consequences have
been so profound and far reaching that it maybe years before we fully comprehend them.

On 3 January , India’s top drug regulator issued emergency approval for two vaccines for
restricted use against covid-19, even though phase iii clinical trials for Covishield and
Covaxin are still ongoing in India.

In a nation with the second highest number of infections in the world and more than 150000
covid-19 deaths, the panic driven by news virus variants fueled approval. At a press
conference 0n 3 January, VG Somani, the drugs controller general of India, said he was
approving the vaccines as an “abundant precaution” against the spread of the highly
transmissible variant found in the United Kingdom.

But a lack of transparency , particularly around Covaxin, India’s first home produced
vaccine, threatens to shatter trust at a time when the country is planning one of the largest and
most difficult vaccination efforts in the world, while deploying its pharmaceutical production
expertise to supply vaccine stocks to countries desperately in need of them.

Two vaccines are currently being administered in India to prevent the spread of severe acute
respiratory syndrome Coronavirus. We assessed the humoral immune response after the first
dose of two vaccinesChAdOx1-nCOV (Covishield) and BBV-152 (Covaxin) in Indian Health
Care Workers (HCW).

HIGHLIGHTS-
 1) This study evaluated the humoral antibody response of two SARS-CoV-2
Vaccines Covishield and Covaxin in Indian health-care workers.
2) Both vaccines showed seropositivity to anti-spike antibody, 21days or more
after the first dose.
3) Responder rates were higher in Covishield recipient compared to Covaxin in
propensity- matched cohorts.
4) Past SARS-CoV-2 infection, presence of comorbidities and vaccine type
received were independent predictors of antibody response after the first
dose.

CONCLUSONS-

While both vaccines elicited immune response, seropositivity rates to anti-spike antibody will
significantly higher in Covishield recipient compared to Covaxin after the first dose. Ongoing
COVAT study will further enlighten the immune response between two vaccines after the
second dose.
 OBJECTIVE OF THE STUDY

1)To study the reasons for getting vaccinated.

2)To study the side effects of vaccination.

3)To study impact of vaccination on immunity.

4)To study the myths about vaccination.

5)To study which is best among COVAXIN and COVISHIELD.

 SCOPE OF THE STUDY

The study basically is conducted to know the awareness among people in relation to
vaccination. From this study we can know how conscious people are about their health, well-
being and immunity after facing the brath of current pandemic COVID-19. It aims to study
the knowledge of people in relation to vaccination and the principles that they kept in mind
while going for vaccination, side-effects that people experienced after vaccination if any.
This study also aims to know people’s confidence in government as well as in vaccines.

But it’s not vaccines that will stop the pandemic, it’s vaccination. We must ensure fair and
equitable access to vaccines and should ensure that every country receives them and can roll
them out to protect their people, starting with the most vulnerable.
 RESEARCH METHODOLOGY

Research: It is a scientific investigation to search for new facts. It is a systematic search for
information.

Research Methodology: It is a way to systematically solve the research problem. It may be

understood as a science of studying how research is done scientifically.

This is a project report which aims at finding the people awareness in relation to vaccination,
health and current pandemic. This study deals with what factors people usually kept in mind
while selecting a particular vaccine, what information do they have about the vaccination,
about its benefits.

This is a descriptive and qualitative project report. Since, it is a qualitative report it aims to
produce contextual real-world knowledge about the behaviors, social structures and shared
beliefs in relation to vaccination. Primary data was collected by choosing Questionnaire as
the survey method and the observations were made accordingly. Convenient sampling
method was used in order to collect the data because this was the simplest method in order to
answer my research questions. Nominal and ordinal scale was used. The questionnaire was
prepared using Google forums. Total 50 respondents were approached through this
questionnaire. The survey consisted of multiple-choice questions with open ended questions.
The language of the questionnaire was kept easy in order to provide convenience to the
respondents, multiple choice questions were kept in order to expand their choices.

RESEARCH DESIGN

Research design is the framework of research methods and techniques chosen by a

researcher. The design allows us to conduct research in a suitable manner and set up
studies for success.

“Research Design is the conceptual structure within which the result should be conducted.

1)Population/Universe- A population may refer to an entire group of people. Objects or

events. In this research, the population city is Kanpur city.

2)Sample- The elementary unit or group in the population which is used as the basis of
selection is called sampling unit.
In this research, Awareness in relation to vaccination is the sampling unit.

3)Sample size-The number of objects or items is called sample size.

In our research, the sample size is 50.

4)Sampling Procedure- This refers to the procedure used to collect the sample.

In this research, sampling procedure is Convenience sampling. It means samples are

collected on based of convenience of researcher.

5)Data Collection-

Primary Data- It is the firsthand information collected by researcher primarily for the
purpose. Here, the primary data is collected through Questionnaire.

Secondary Data- It refers to the collected by some other researcher.

Statistical Analysis- Statistical analysis is the science of collecting data and uncovering
patterns and trends.

Statistical Techniques- Statistical technique in this project is Percentage method.

 PRIMARY STUDY

This project report is based on Primary study and the method used in this project in order to
collect the data is Questionnaire. I have formed Five hypothesis for my project report that
will be discussed in the “Data Analysis and Interpretation part.”

“DATA ANALYSIS AND DATA INTERPRETATION”

Hypothesis 1- “People got themselves vaccinated due to health reasons.”

 Column1
16%

45%

29%

11%

Health reasons Doctor Compulsion by gov Recommendation Other

The above figure shows various reasons people considered in order to get their vaccination
done. They had total five options namely- health reasons, doctor, compulsion by government,
recommendation. According to the data collected 60.70% (health reasons), 14.3%(doctor),
39.30% (compulsion by government) , recommendation(21.4%) and others(10.7%). So, the
highest number respondents selected health reasons for getting vaccinated.

Therefore, hypothesis proves to be true.

Hypothesis 2) People experienced body pain as side effect after vaccination.

 Column 2
17% 23%

6%

54%

Headache Body pain Conscious Drowsiness Other

According to the data collected 28.60%(headache), 67.90% (body pain), 7.10%(conscious),

21.40%(drowsiness) and 28.60%(other). So, the highest number of respondents selected body
pain as side effect after vaccination.

Therefore, hypothesis proves to be true.

Hypothesis 3) Vaccination will help in boosting immunity.

Column 3
25%

4%

71%

Yes No Maybe
According to the data collected 71.40%(yes), 3.60%(no) and 25%(maybe). So, highest
number of respondents believed that vaccination will help in boosting immunity.

Therefore, hypothesis proves to be true.

Hypothesis 4) People with severe diseases should not go for vaccination.

Column 4
3%
30%
42%

25%

Vaccines have side-effects

Covid vaccines are untested and dangerous
People with severe diseases should not go for vaccination
Other

According to the data collected 42% (vaccines have side-effects), 25%(Covid vaccines are
untested and dangerous), 30%(people with severe diseases should not go for vaccination) and
3%(other). So, the highest number of respondents selected vaccines have side-effects as myth
of getting vaccinated.

Therefore, hypothesis proves to be untrue.

Hypothesis 5) Most of the people went for COVAXIN.

Since, it was an open-ended question many people gave their reasons for choosing
COVAXIN and COVISHIELD.

According to the data collected most of the people went for COVISHIELD due to its
popularity, effectiveness as well as recommendations from their family doctor, friends and
family.
Therefore, hypothesis proves to be untrue in this situation.
 FINDINGS AND CONCLUSIONS

According to the above data interpretation and analysis following conclusions have been
made.

Hypothesis 1- People selected health reasons as the major cause for getting vaccinated.

Hence, in this case hypothesis proved to be true.

Hypothesis 2- Most of the people experienced body pain after getting vaccinated.

Hence, in this case hypothesis proved to be true.

Hypothesis 3- Most of the people believed that vaccination would help in boosting their
immunity.

Hence, in this case hypothesis proved to be true.

Hypothesis 4- Most of the people believed that vaccination has its own side-effects.

Hence, in this case hypothesis proves to be untrue.

Hypothesis 5- Most of the people went for COVISHIELD due to its efficiency, availability as
well as high recommendations from their friends and family.

Hence, in this case hypothesis proved to be untrue.

 LIMITATIONS

Considering the current pandemic this report was prepared through online mode so, the data
collected will be limited in its approach. The sample size of 50 respondents is too small in
order to make any accurate conclusions from the data collected through Questionnaire. There
might have been tendencies among the respondents to amplifying or filter their responses
under the testing. In some cases, respondents avoided to answer some of the questions
whereas some refused to fill the Questionnaire. It is possible that some potential source might
have remained untapped. Since the result has been drawn b on the basis of information
provided by the respondents therefore there is a high possibility of error in the data. There are
chances that various questions might have remained untackled through this project report.
Though the language of the Questionnaire was well defined but since, the questionnaire was
in English many people avoided filling the questionnaire. The responses were collected
purely on the basis of the knowledge of the respondents about vaccination however, there are
no research or medical evidence of the data collected For example- there is no medical report
stating that vaccination has resulted in creation of antibodies that will help in boosting the
immunity of the respondents. Lastly, the data collected, and interpretation made through this
report is not declared accurate by any concerned authority working in this field.

CONCLUSIONS
During the pandemic period, a strong demand and high acceptance of COVID-19 vaccination
have been shown among the Kanpur population. People have become more conscious about
their health; they are aware about the pros and cons of vaccination in relation to the current
pandemic. They know which vaccine is effective for them. The data collected shows that
large number of actively participated in the vaccination drive.
 RECOMMENDATIONS

Though the government is making constant efforts in order to tackle the current pandemic
situation.

To expand vaccination coverage, immunization programs should be designed to remove

barriers in terms of vaccine price and vaccination convenience, and health education and
communication from authoritative sources are important ways to alleviate public concerns
about vaccine safety.
 ANNEXURE

QUESTIONNAIRE

1) Name
2) Age
a) 18-30
b) 30-50
c) Above 50

3)Gender

a) Male

b) Female

4)Have you got your vaccination done?

a) Yes

b) No

5)Are you fully or partially vaccinated?

a) Fully

b) Partially

6)Which vaccine did you went for?

a) Covaxin

b) Covishield

c) Other

7)What is the purpose of getting your vaccination done?

a) Health reasons

b) Doctor

c) Compulsion by government

d) Recommendation
 e) Other

8)Do you think getting vaccinated is necessary?

a) Yes

b) No

c) Maybe

9)Did you experienced any sort of side effects after getting vaccinated?

a) Headache

b) Body pain

c) Conscious

d) Drowsiness

e) Other

10)Do you think vaccination will help you in boosting your immunity?

a) Yes

b) No

c) Maybe

12)What are your myths in relation to vaccination?

a) Vaccination has side-effects

b) Vaccines are untested and dangerous

c) People with severe diseases should not go for vaccination

d) Other

11)Reasons for choosing Covaxin or Covishield?

 BIBLIOGRAPHY

Scholar.google.co.in

www.google.com

www.who.int

www.wikipedia.org

www.seruminstitute.com

www.mpnrc.org

www.bharatbiotech.com

economictimes.indiatimes.com

www.thehindu.com

www.raps.org

www.hindustantimes.com
Thank you